EA201400492A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA

Info

Publication number
EA201400492A1
EA201400492A1 EA201400492A EA201400492A EA201400492A1 EA 201400492 A1 EA201400492 A1 EA 201400492A1 EA 201400492 A EA201400492 A EA 201400492A EA 201400492 A EA201400492 A EA 201400492A EA 201400492 A1 EA201400492 A1 EA 201400492A1
Authority
EA
Eurasian Patent Office
Prior art keywords
combination
lamivudina
abakavir
foundation
pharmaceutical compositions
Prior art date
Application number
EA201400492A
Other languages
Russian (ru)
Inventor
Майа Михоци
Тияна Любичик
Ана Мартинчик
Original Assignee
Плива Хрватска Д.О.О.
Тева Фармасьютикал Индастриз, Лтд.
Общество С Ограниченной Ответственностью "Тева"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива Хрватска Д.О.О., Тева Фармасьютикал Индастриз, Лтд., Общество С Ограниченной Ответственностью "Тева" filed Critical Плива Хрватска Д.О.О.
Priority to EA201400492A priority Critical patent/EA201400492A1/en
Publication of EA201400492A1 publication Critical patent/EA201400492A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение имеет отношение к медицине, в частности к фармацевтическому производству, и предоставляет фармацевтическую композицию для лечения болезней, связанных с ретровирусными инфекциями, в частности ВИЧ-инфекцией, содержащую комбинацию основания абакавира и ламивудина в качестве активных веществ. Изобретение также предоставляет способ производства фармацевтической композиции и ее применения при ВИЧ-инфекции.The present invention relates to medicine, in particular to pharmaceutical production, and provides a pharmaceutical composition for treating diseases associated with retroviral infections, in particular HIV infection, containing a combination of the base of abacavir and lamivudine as active substances. The invention also provides a method for producing a pharmaceutical composition and its use in HIV infection.

EA201400492A 2014-05-22 2014-05-22 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA EA201400492A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201400492A EA201400492A1 (en) 2014-05-22 2014-05-22 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201400492A EA201400492A1 (en) 2014-05-22 2014-05-22 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA

Publications (1)

Publication Number Publication Date
EA201400492A1 true EA201400492A1 (en) 2015-11-30

Family

ID=54704902

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400492A EA201400492A1 (en) 2014-05-22 2014-05-22 PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF THE FOUNDATION OF ABAKAVIR AND LAMIVUDINA

Country Status (1)

Country Link
EA (1) EA201400492A1 (en)

Similar Documents

Publication Publication Date Title
EA201891186A1 (en) ANTIBODIES, NEUTRALIZING THE VIRUS OF HUMAN IMMUNODEFICIENCY
EA201890126A1 (en) NEW BICYCLIC DERIVATIVES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201790389A1 (en) PYRROPYRIMIDINE COMPOUNDS USED AS AN AGLIST TLR7
EA201990043A1 (en) ANTIBACTERIAL CONNECTIONS
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201691442A1 (en) N-AZASPROCYCLOALKAN-SUBSTITUTED N-HETEROARRYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING SHP2 ACTIVITY
CR20140200A (en) SOLID FORMS OF 3- (5-AMINO-2-METHYL-4-OXO-AH-QUINAZOLIN-3-IL) -PIPERIDIN-2,6-DIONA, AND ITS PHARMACEUTICAL COMPOSITIONS AND THEIR USES
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
BR112015021888A8 (en) dna-pk inhibitors, their uses and pharmaceutical composition
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
EA201992133A1 (en) PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
MY193728A (en) Muscarinic receptor agonists
EA202090098A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201690687A1 (en) REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY
DOP2016000253A (en) NEW COMPOUNDS
EA201590667A1 (en) ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES
EA201692003A1 (en) MACROCYCLIC DERIVATIVES OF PYRIMIDINE
EA201591406A1 (en) C-19 MODIFIED TRITERPENOIDS WITH INHIBITOR ACTIVITY OF HIV MATURATION
CL2015002897A1 (en) Bace1 inhibitors
TR201821116A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POSACONAZOL AND THE MANUFACTURING METHOD
EA202090014A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA201790495A1 (en) PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION